Table 2.
Parameters/days | Groups/treatment | |||
---|---|---|---|---|
T0 (0.0) | T1 (300 μg/L) | T2 (600 μg/L) | T3 (900 μg/L) | |
ROS (optical density) | ||||
10 | 0.36 ± 0.03 | 0.37 ± 0.02 | 0.40 ± 0.03 | 0.84 ± 0.07∗ |
20 | 0.37 ± 0.01 | 0.39 ± 0.01 | 0.67 ± 0.02∗ | 0.86 ± 0.05∗ |
30 | 0.39 ± 0.04 | 0.42 ± 0.03 | 0.75 ± 0.02∗ | 0.92 ± 0.05∗ |
TBARS (nmol/TBARS formed/mg protein/min) | ||||
10 | 37.42 ± 2.93 | 39.23 ± 1.95 | 41.07 ± 1.15 | 54.93 ± 2.74∗ |
20 | 38.89 ± 1.94 | 40.68 ± 2.95 | 50.44 ± 1.97∗ | 56.25 ± 3.92∗ |
30 | 40.02 ± 3.94 | 41.95 ± 2.93 | 51.88 ± 2.34∗ | 58.83 ± 4.53∗ |
Reduced GSH (μmol/g tissue) | ||||
10 | 8.66 ± 1.17 | 7.65 ± 0.06 | 6.64 ± 0.13 | 5.64 ± 0.15∗ |
20 | 8.38 ± 1.12 | 7.44 ± 1.10 | 6.05 ± 0.02 | 5.56 ± 0.12∗ |
30 | 8.35 ± 1.14 | 7.38 ± 1.05 | 5.93 ± 1.15∗ | 5.48 ± 0.14∗ |
Antioxidant enzymes | ||||
SOD (units/mg protein) | ||||
10 | 11.65 ± 0.12 | 10.97 ± 0.12 | 10.29 ± 0.13 | 10.27 ± 0.11 |
20 | 11.64 ± 0.15 | 10.32 ± 0.15 | 9.46 ± 0.15 | 7.58 ± 0.14∗ |
30 | 10.75 ± 0.18 | 9.68 ± 0.18 | 7.10 ± 0.18∗ | 7.04 ± 0.17∗ |
CAT (units/min) | ||||
10 | 8.70 ± 0.19 | 7.52 ± 0.19 | 7.14 ± 0.19 | 5.16 ± 0.19∗ |
20 | 7.99 ± 0.17 | 7.35 ± 0.16 | 5.63 ± 0.16∗ | 5.03 ± 0.16∗ |
30 | 7.95 ± 0.16 | 7.02 ± 0.16 | 5.46 ± 0.16∗ | 4.95 ± 0.16∗ |
POD (units/μg) | ||||
10 | 4.08 ± 0.09 | 3.56 ± 0.09 | 2.78 ± 0.09∗ | 2.47 ± 0.08∗ |
20 | 4.03 ± 0.08 | 3.47 ± 0.08 | 2.63 ± 0.08∗ | 2.41 ± 0.08∗ |
30 | 3.96 ± 0.08 | 3.39 ± 0.08 | 2.55 ± 0.08∗ | 2.38 ± 0.08∗ |
In each row, values (Mean ± SE) bearing asterisks differ significantly (P ≤ 0.05) from that of values in untreated (T0 negative control) fish. T1, T2, and T3 are positive control and dose based.